1. Home
  2. GKOS vs IREN Comparison

GKOS vs IREN Comparison

Compare GKOS & IREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$238.12

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Iris Energy Limited

IREN

Iris Energy Limited

N/A

Current Price

$14.41

Market Cap

8.3B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
IREN
Founded
1998
2018
Country
United States
Australia
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.3B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
GKOS
IREN
Price
$238.12
$14.41
Analyst Decision
Strong Buy
Buy
Analyst Count
13
20
Target Price
★ $243.85
$56.69
AVG Volume (30 Days)
1.5M
★ 54.9M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$507,442,000.00
★ $707,007,000.00
Revenue This Year
$53.82
$237.43
Revenue Next Year
$28.56
$199.66
P/E Ratio
★ N/A
N/A
Revenue Growth
32.33
★ 41.11
52 Week Low
$93.78
$14.98
52 Week High
$255.19
$70.71

Technical Indicators

Market Signals
Indicator
GKOS
IREN
Relative Strength Index (RSI) 59.90 26.73
Support Level $147.72 N/A
Resistance Level $255.19 $44.21
Average True Range (ATR) 11.84 2.13
MACD -1.49 -0.17
Stochastic Oscillator 43.31 2.29

Price Performance

Historical Comparison
GKOS
IREN

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About IREN Iris Energy Limited

IREN owns data centers powered by renewable energy in Canada and the US for bitcoin mining and AI cloud infrastructure. The company is in the process of converting its existing bitcoin capacity for AI purposes and securing new power and land supply to expand its data center operations. IREN works closely with industry leaders in AI, such as Microsoft, to support their cloud infrastructure ambitions.

Share on Social Networks: